APA (7th ed.) Citation

Alidjinou, E. K., Deldalle, J., Hallaert, C., Robineau, O., Ajana, F., Choisy, P., . . . Bocket, L. (2017). RNA and DNA Sanger sequencing versus next-generation sequencing for HIV-1 drug resistance testing in treatment-naive patients. Journal of Antimicrobial Chemotherapy (JAC), 72(10), 2823. https://doi.org/10.1093/jac/dkx232

Chicago Style (17th ed.) Citation

Alidjinou, E. K., J. Deldalle, C. Hallaert, O. Robineau, F. Ajana, P. Choisy, D. Hober, and L. Bocket. "RNA and DNA Sanger Sequencing Versus Next-generation Sequencing for HIV-1 Drug Resistance Testing in Treatment-naive Patients." Journal of Antimicrobial Chemotherapy (JAC) 72, no. 10 (2017): 2823. https://doi.org/10.1093/jac/dkx232.

MLA (9th ed.) Citation

Alidjinou, E. K., et al. "RNA and DNA Sanger Sequencing Versus Next-generation Sequencing for HIV-1 Drug Resistance Testing in Treatment-naive Patients." Journal of Antimicrobial Chemotherapy (JAC), vol. 72, no. 10, 2017, p. 2823, https://doi.org/10.1093/jac/dkx232.